Torno Capital’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-48,479
Closed -$360K – 93
2026
Q1
$360K Buy
48,479
+28,479
+142% +$185K 0.05% 44
2025
Q4
$126K Buy
+20,000
New +$117K 0.01% 78

Torno Capital's KZR Position: Q2 2026 in Review

Torno Capital sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 48,479 shares — an estimated $360K sold.

Torno Capital first reported a position in KZR in Q4 2025 and held it in 2 quarters. The position peaked at $360K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • Torno Capital reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Torno Capital sold 48,479 Kezar Life Sciences shares in Q2 2026, an estimated $360K.
  • Torno Capital first reported a position in Kezar Life Sciences in Q4 2025 and held it in 2 quarters.
  • Torno Capital's Kezar Life Sciences position peaked at $360K in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Torno Capital's 13F filing for Q2 2026, filed 14 Aug 2026.